FLASCO Proudly Announces the Release of a New White Paper Providing Practical Guidance on Expanding Access to Innovative Cancer Therapies
Posted March 24, 2025
FLASCO is pleased to share a new white paper exploring the transformative potential of bispecific antibodies (BsAbs) in lymphoma treatment. Developed with support from Genentech, the paper offers actionable recommendations for wider adoption across Florida. With demonstrated success in clinical trials, BsAbs represent a significant advancement in cancer care. The report highlights the importance of... Read More »
